Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
about
Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplificationMicroarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivoRole of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo.Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCRRapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probesA real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses.Identification of small molecule compounds that selectively inhibit varicella-zoster virus replicationMutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.Promoter activation by the varicella-zoster virus major transactivator IE62 and the cellular transcription factor USF.Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination.A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.Vaccination to prevent varicella and shingles.Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain.Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVaxGenotypic analysis of varicella-zoster virus and its seroprevalence in Finland.Use of Saliva to Identify Varicella Zoster Virus Infection of the GutPrevention of shingles: safety and efficacy of live zoster vaccine.Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination.Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine.Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.Molecular studies of the Oka varicella vaccine.Insights into the function of tegument proteins from the varicella zoster virus.Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.Infectivity of herpes simplex virus type-1 (HSV-1) amplicon vectors in dendritic cells is determined by the helper virus strain used for packaging.Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children.Complete DNA sequences of two oka strain varicella-zoster virus genomes.
P2860
Q28757353-F8BEF021-F9A4-4D26-84ED-151543E00C54Q30531746-EEDDF71F-B0CB-4C17-AF19-B9200848DB1CQ33724286-84CF513A-AA67-4ED2-8065-C0DE1F82F046Q33969481-8BFBACB8-5375-48DA-80A2-6E1E8CC3C28BQ33970458-E9DCEE4E-E1E8-4333-8E4E-858B3ECA0890Q34441066-31AC7E59-FE64-43A4-8C99-00D28552F440Q34471804-E8B6FF62-7C68-40A3-9099-7C61EDFFB6D1Q34977329-9FA465B8-B308-4368-A289-90CF69656CB1Q35023792-66292094-A3AB-4D27-B062-DDDF43FD28E7Q35101401-4D465941-4CD0-4CF9-8B71-3CB7D5D28366Q35101407-DECC625A-BA63-4B9A-8215-C75F73B48693Q35397475-7169E43D-ABDA-4A41-8D29-0514E0813212Q35690518-6ABA295A-1632-41DE-AC46-56466F4A8A6EQ35693108-6DD79ABF-C0C4-4E2C-8EE3-7E3D96064228Q36095164-2234EDB9-7958-45DE-968F-9313D48DCC99Q36167494-E28F08A0-9D99-42EC-B0F0-21D9395B7628Q36642986-8D329FDD-B389-4692-A822-E0C330B96ECCQ36931965-10888190-5A7F-4237-94CB-4E714196820EQ37668870-C5433F55-F3C7-43E0-B1A4-6D5037F92773Q37702470-09D27E3A-3417-4706-8A2D-0146FDE8F414Q37932527-A6B74B7C-59C0-4A1E-AF49-383F2D10F0B3Q38553727-D01EBDC3-B01D-4B44-8D83-348C732E3294Q39685724-B695E04C-8FA9-4C51-A977-E4B401F0E47CQ40112693-02424534-CA48-4790-9C4D-DB35E98724F7Q40330700-18338131-3A66-4551-8DE3-77F3920F3513Q43251025-EB3B1443-10D2-4630-9B0E-4F625B0A7BB6
P2860
Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Nucleotide sequences that dist ...... ricella-zoster virus isolates.
@ast
Nucleotide sequences that dist ...... ricella-zoster virus isolates.
@en
type
label
Nucleotide sequences that dist ...... ricella-zoster virus isolates.
@ast
Nucleotide sequences that dist ...... ricella-zoster virus isolates.
@en
prefLabel
Nucleotide sequences that dist ...... ricella-zoster virus isolates.
@ast
Nucleotide sequences that dist ...... ricella-zoster virus isolates.
@en
P2093
P356
P1476
Nucleotide sequences that dist ...... ricella-zoster virus isolates.
@en
P2093
Lekstrom K
Yoshikawa T
P304
P356
10.1086/315335
P407
P577
2000-03-01T00:00:00Z